Michael Morris discusses integrating PSMA PET into high-risk biochemical recurrence, where systemic therapy follows the EMBARK regimen. Dr. Morris treats PSMA-avid oligoprogressive lesions with ...
Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial - Beyond the Abstract ...
Transdermal Application of H100 Gel to the Penile Shaft in Patients with Peyronie's Disease Infiltrates the Tunica Albuginea - Beyond the Abstract ...
Comprehensive Analysis of microRNA Expression Provides Mechanistic Insights into Transcriptomic Alteration in Primary and Metastatic Testicular Germ Cell Tumors - Beyond the Abstract ...
The Kurt extraperitoneal ligamentopexy: A new surgical method with uterine preservation for pelvic organ prolapse, "Beyond the Abstract," by Sefa Kurt and Mehmet Tunc Canda ...
Purine Nucleoside Phosphorylase as a Target for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesions - Beyond the Abstract ...
Hashim Hashim joins Diane Newman for a conversation on the definitions of lower urinary tract dysfunction and the role and timing of urodynamics in the diagnosis of the specific condition. They also ...
Multi-Institutional External Validation of the European Risk Classification for High-Grade Ta Non-Muscle-Invasive Bladder Cancer - Beyond the Abstract ...
(UroToday.com) The 2024 Southeastern Section of the AUA (SESAUA) annual meeting featured a bladder cancer session and a presentation by Dr. Shreyas Joshi discussing the prevalence, trends, and costs ...
(UroToday.com) The 2026 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Wolfgang Fendler discussing external validation of new prostate cancer risk groups by PSMA-PET.
The 2026 ProsTIC annual meeting featured a Lutetium-177 session and a presentation by Dr. Renu Eapen discussing whether there is a role for 177 Lu-PSMA-617 prior to or after surgery.
The Prostate Cancer Foundation framework summarizes five major components used for risk stratification: PSA level, tumor grade on biopsy, T stage, extent of disease including nodal or distant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results